Raymond James Financial Services Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-18,999
Closed -$939K 3044
2020
Q3
$939K Buy
18,999
+7,809
+70% +$441K ﹤0.01% 1587
2020
Q2
$588K Buy
11,190
+1,109
+11% +$52.6K ﹤0.01% 1806
2020
Q1
$355K Buy
10,081
+645
+7% +$37.7K ﹤0.01% 1746
2019
Q4
$825K Buy
9,436
+1,996
+27% +$175K ﹤0.01% 1657
2019
Q3
$631K Sell
7,440
-231
-3% -$20.6K ﹤0.01% 1751
2019
Q2
$807K Buy
7,671
+134
+2% +$13.5K ﹤0.01% 1613
2019
Q1
$796K Buy
7,537
+64
+0.9% +$6.43K ﹤0.01% 1591
2018
Q4
$625K Buy
7,473
+821
+12% +$74.3K ﹤0.01% 1526
2018
Q3
$678K Sell
6,652
-83
-1% -$8.01K ﹤0.01% 1699
2018
Q2
$545K Buy
+6,735
New +$535K ﹤0.01% 1811

Other funds holding NGVT

Raymond James Financial Services Advisors's NGVT Position: Q4 2020 in Review

Raymond James Financial Services Advisors sold out of Ingevity (NGVT) in Q4 2020, closing a stake of 18,999 shares — an estimated $939K sold.

Raymond James Financial Services Advisors first reported a position in NGVT in Q2 2018 and held it in 10 quarters. The position peaked at $939K in Q3 2020. 285 funds tracked by Wall St. Rank hold NGVT as of Q4 2020.

  • Raymond James Financial Services Advisors reported no remaining Ingevity position as of Q4 2020 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 18,999 Ingevity shares in Q4 2020, an estimated $939K.
  • Raymond James Financial Services Advisors first reported a position in Ingevity in Q2 2018 and held it in 10 quarters.
  • Raymond James Financial Services Advisors's Ingevity position peaked at $939K in Q3 2020.
  • 285 funds tracked by Wall St. Rank held Ingevity as of Q4 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.